PriceSensitive

Cloud DX sells subsidiary, completes first stage of restructuring

Health Care, Market News, Technology
TSXV:CDX.H
17 December 2024 06:58 (EST)
Image via Cloud DX

(Source: Cloud DX.)

Cloud DX (TSXV:CDX) reported the sale of its wholly owned subsidiary, Cloud Diagnostics Canada ULC to 1493907 B.C. Ltd.

In a news release, the Kitchener, Ontario-based company called this transaction a significant step in its restructuring process.

The transaction has been in the works since June 2024 and was concluded in connection with a notice of intention to make a proposal proceeding. The sale was completed in accordance with the terms of a Subscription Agreement and the provisions of a reverse vesting order granted by the Supreme Court of British Columbia on November 19, 2024.

As part of the transaction:

16538363 Canada Ltd. is expected to be assigned into bankruptcy under to the Bankruptcy and Insolvency Act.

Cloud DX Inc. is a remote patient monitoring company that is a Health Canada-licensed, U.S. Food and Drug Administration-registered medical device manufacturer and software developer offering a complete end-to-end virtual healthcare platform called Cloud DX Connected Health.

Cloud DX stock (TSXV:CDX) last traded at $0.125 and has risen 38.89 per cent since the year began.

Join the discussion: Find out what everybody’s saying about this stock on the Cloud DX Inc. Bullboard investor discussion forum, and check out the rest of Stockhouse’s stock forums and message boards.

The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.


Related News